LogoLogoLogoLogoLogo
  • Portfolio
  • News
    • In the News
    • Press Releases
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us
  • Portfolio
  • News
    • In the News
    • Press Releases
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

RxLightning Closes $17.5M Series A to Accelerate Growth and Remove Barriers to Essential Specialty Medications

...

Aster Insights Announces that The University of Kansas Cancer Center will join the Oncology Research Information Network (ORIEN)

ORIEN Member Presentations at 2023 ASCO Demonstrate Unique Value of Aster Insights’ Data

Private AI and Replica Analytics announce partnership to tackle data privacy

Aster Insights Names Dr. Anand Shah as Chief Executive Officer

Twist Bioscience and Aster Insights Partner on Launch of Next Generation Oncology Panel for Cancer Research

Clinical ink Announces New Continuous Glucose Monitoring Solution

RCT-DUPLICATE Findings Demonstrate Capability of Real-World Evidence Studies to Reach Conclusions Similar to Randomized Clinical Trials

Replica Analytics unveils Replica Synthesis 3.0

M2GEN Rebrands to Aster Insights

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104
USA

Contact Us
Cookie Settings

 

In the News

  • RxLightning Closes $17.5M Series A to Accelerate Growth and Remove Barriers to Essential Specialty Medications

  • Aster Insights Announces that The University of Kansas Cancer Center will join the Oncology Research Information Network (ORIEN)

  • Inbound Health launches at-home post-surgery care

  • ‘A Startup Supporting Startups’: Inside Merck Digital Sciences Studio

Subscribe to Updates via Email

Enter your email address to subscribe to McKesson Ventures updates.

©2021 McKesson Ventures | Privacy Notice | Disclaimer
@McK_Ventures
McKesson Ventures LinkedIn